Veterinary Medicines

Parvoruvac

Authorised
  • Erysipelothrix rhusiopathiae, serotype 2, strain IM 950, Inactivated
Download as PDF

Product identification

Medicine name:
Parvoruvac
Active substance:
  • Erysipelothrix rhusiopathiae, serotype 2, strain IM 950, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Erysipelothrix rhusiopathiae, serotype 2, strain IM 950, Inactivated
    1.00
    Protective Dose
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Tiergesundheit GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
  • Ceva-Phylaxia Veterinary Biologicals Co. Ltd.
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 490a/87
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."